c-erbB3 Protein Expression in Breast Cancer
Author Information
Author(s): R Naidul, M Yadav, S Nair, MK Kutty
Primary Institution: University of Malaya
Hypothesis
The study investigates the expression of c-erbB3 protein in primary breast carcinomas and its association with clinical parameters.
Conclusion
Overexpression of c-erbB3 protein is significantly associated with poorly differentiated breast tumors and may serve as a marker for poor prognosis.
Supporting Evidence
- 67% of comedo DCIS cases showed overexpression of c-erbB3.
- 52% of invasive ductal carcinomas exhibited strong c-erbB3 positivity.
- 71% of poorly differentiated tumors were strongly positive for c-erbB3.
- High percentages of oestrogen receptor-negative (59%) and lymph node-positive (63%) tumors were c-erbB3 positive.
Takeaway
This study looked at a protein called c-erbB3 in breast cancer samples and found that many tumors with high levels of this protein were more aggressive.
Methodology
The study used immunohistochemical techniques to evaluate c-erbB3 expression in breast cancer tissues.
Limitations
The study did not include a follow-up on patient outcomes or a larger sample size for more definitive conclusions.
Participant Demographics
Patients included 66 diagnosed under 50 years and 38 diagnosed at 50 years or older.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website